Konstantinos
C Papakonstantinou , Julia
K Terzis , Elizabeth
Kamin , Janos Luka: Early effect of gene therapy
on a direct muscle neurotization model. J Reconstr. Microsurg. 21.
(6):383-389, 2005.
Roback, J. D., Hillyer, C. D., Drew, W. L., Laycock, M. E., Luka, J.,
Mocarski, E. S., Slobedman, B., Smith, J. W., Soderberg-Naucler, C., Todd,
D.,Woxenius, S., Busch, M.P.: Multicenter evaluation of PCR methodologies
to detect cytomegalovirus DNA in blood donors. Transfusion, 41: 1249-1257,
2001
Dumont, L. J., Luka, J., VandenBroeke, T., Whitley, P., Ambruso,
D. A., Elfath, M.D.: The effect of leukocyte-reduction method on the amount
of human cytomegalovirus (CMV) in blood products - a comparison of apheresis
and filtration methods. Blood, 97 (11). 2001
Bostrom, B. C., Simonton, S. C., Drehner, D. M., McKercher, S. W., Luka, J., P., Roudier, J.:
A syndrome of familial splenomegaly and lymphadenopathy associated with human herpesvirus-7 (HHV-7).
Journal of Pediatric Hematology/Oncology. 22(4):376, July/August 2000.
Toussirot, E., Wendling, D., Tiberghien, Luka, J., P., Roudier, J.:
Decreased T-cell Precursor frequencies to Epstein-Barr virus glycoprotein
gp 110 in peripheral blood correlate with disease activity and severity in
patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 59:
533-538. 2000 (editorial pages 497-499)
Toussirot, E., Auger I., Roudier, C., Luka, J., Wendling, D., Tiberghien,
P., Roudier, J.: HLA-DR polymorphism influences T cell precursor frequencies
to EBV gp110. Implications for the association of HLA-DR antigens with rheumatoid
arthritis. TissueAntigens, 54: 146-152. 1999
Krueger, R. F., Ablashi, D. V., Whitman, J. I., Luka, J., Rojo, J.:
Clinical pathology and reactivation of human lymphotropic herpesviruses. Revista
Medica del Hospital General, 61. 4. 226-240, 1998.
Wagner, M., Muller-Berghaus, J., Schroeder, R., Sollberg, S., Luka, J.,
Leyssens, N., Schneider, B., Kruger, G.R.F: Human Herpesvirus-6 (HHV-6) Associated
Necrotizing Encephalitis in Griscelli's Syndrome. J. Medical Virology, 53:
306-312. 1997.
McGuire, T., Greally, J., Leon, J., Luka, J.: Epstein-Barr virus
Types A, B and Herpes Virus-6 in patients presenting with recurrent upper
respiratory inflamation, persistent paravertebral thoracolumbar muscle spasm
and fattigue, by polymerase chain reaction (PCR). In Vitro. 2: 1. 1997.
Luka, J. J. Gubin, C. Afflerbach, S. D. Carson and G. F. Krueger:
Detection of human herpesvirus-6 (HHV-6) genomes by in situ PCR in tissues
from Kawasaki disease and in coronary arteries of transplanted hearts . Cell
Vision, 4: 371. 1995.
K. Wu F, Luka J, S Joshi S, et al. Characterization of
a human herpes virus 6 (HHV-6) and Epstein-Barr virus (EBV) associated
leukemic cell line, J6-6 [J]. Chinese J Cancer Res, 6 (3) : 157-168.
1994
G.R.F Krueger, A. Guenther, R. Knuefermann, U. Kluepperberg, J. Luka,
G.R. Pearson, D.V. Ablashi, M. Juecker, H. Tesch: Human Herpesvirus-6 in Hodgkin's
disease: Cellular expression of viral antigens as compared to the oncogens
Met and Fes, the tumor suppressor gene product p53, and the Interleukins 2
and 6. In Vivo, 8: No.: 4: 501-516, 1994
J. Rojo, V.E. Ferrer Argote, U. Klueppelberg, G.R.F. Krueger, E. Eidt, D.V.
Ablashi, J. Luka, H. Tesh : Semi-Quantitative in Situ hybridization
and immunohistology for antigen expression of Human Herpesvirus-6 in various
lymphoproliferative diseases. In Vivo, 8: No.: 4: 517-526, 1994
Bashir, R., Luka, J., Cheloha, K., Chamberlain, M., Hochberg, F.:
Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS
patients. Neurology. 43. 2358-2362. 1993
Bray,P.F., Luka, J., Bray, P.F., Culp, K.W., Schlight, J.P.: Antibodies
against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and
two pentapeptide sequence identities between EBNA and myelin basic protein.
Neurology, 42. 1798-1804. 1992.
Goldschmidts, W.L., Bhatia, K., Carolan, M., Luka, J., Magrath, I.T.:
Inhibition of the EBV lytic cycle by sequence specific antisense oligo nucleotides.
Epstein-Barr Virus and Human Disease:1990. Ed.s.: Ablashi DV, Huang AT, Pagano
JS, Pearson GR, Yang CS. The Humana Press, pp. 237-240. 1992.
Shu-Yuan Liao, David T. Purtilo, J. Luka.: Elevated IgA and IgG anti-viral
capsid antigen (VCA) antibodies in uterine cervical carcinoma is associated
with detection of EBV genome by polymerase chain reaction. Epstein-Barr Virus
and Human Disease:1990. Ed.s.: Ablashi DV, Huang AT, Pagano JS, Pearson GR,
Yang CS. The Humana Press, pp. 1992.
G.F. Krueger, J. Sievert, M. Juecker, H. Tesh, V. Diehl, D.V. Ablashi, N.
Balachandran, J. Luka.: Hodgkin's cells express human herpesvirus-6
antigens. J. Viral. Dis. 1. 15-23. 1992
A. Guenther, G.R.F. Krueger, B. Koch, J. Luka, D.V. Ablashi, H. Tesch,
M, Juecker.: Human herpesvirus-6 in Hodgkin's disease. Anticancer Res. 12
(6A). p. 1861. 1992.
Lusso, P., Ablashi, D.V., Luka, J.: Interaction between HHV-6 and
other viruses. In "Human Herpesvirus-6: Epidemiology, Molecular Biology
and Clinical Pathology" Ed.s.: Ablashi, Krueger, Salahuddin. Elsevier
Science Publishers. Perspectives in Medical Virology. vol. 4. "Human
Herpesvirus-6" pp. 121-133. 1992.
Luka J.: Infection, latency and immortalization of human cells with
HHV-6. In "Human Herpesvirus-6: Epidemiology, Molecular Biology and Clinical
Pathology" Ed.s.: Ablashi, Krueger, Salahuddin. Elsevier Science Publishers.
Perspectives in Medical Virology. vol. 4. "Human Herpesvirus-6"
pp. 49-56. 1992.
Falk, K., Ernberg, I., Sakthivel, R., Christensson, B., Grierson, H.L.,
Okano, M., Davis, J.R., Luka, J., Johnson, D.R., Klein, G., Purtilo,
D.T.: Expression of Epstein-Barr virus encoded proteins and B-cell antigens
in fatal infectious mononucleosis. Int. J. Cancer, 46.976-984. 1990.
Luka, J., Okano, M., Thiele, G.: Isolation of Human Herpesvirus-6
from clinical specimens using human fibroblast cultures. J. Clin. Lab. Investigation.
4. 483-486. 1990.
Thiele, G.M., Okano, M., Luka, J., Bashir, R., Purtilo, D.T.: Spectrum
of EBV Diagnosis. In Press
Roudier, J., Petersen, J., Rhodes, G.H. Luka, J., Carson, D.A.: Susceptibility
to rheumatoid arthritis maps to a five amino acid sequence recognized by T
and B cells and shared by the HLA Dw4 DR ß 1 chain and the Epstein-Barr
virus glycoprotein gp 110. Proc. Natl. Acad. Sci. 1989.
Okano, M., Luka, J., Thiele, G.M., Sakiyama, Y., Matsumoto, S., Purtilo,
D.T.: Human Herpesvirus-6 infection and Kawasaki disease. J. Clin. Microbiology,
27. 10. 2379-2380. 1989.
S.Z. Salahuddin, D.V. Ablashi, S.F. Josephs, J. Luka, G.R. Pearson,
B. Kramarsky and R.C. Gallo : Human Herpesvirus-6 ( Human B-Lymphotropic Virus
). In " Epstein-Barr Virus and Human Disease " 1988. pp. 461-472.
Ed. D.V. Ablashi, et al. Published by The Humana Press, Inc., Clifton, NJ.
USA
D.V. Ablashi, J. Luka, A. Buchbinder, S.F. Josephs, T. Llana, C.
Zompetta, a. Faggioni, P. Lusso, G.R. Pearson, S.Z. Salahuddin and R.C. Gallo
: Interaction of HBLV (HHV-6) with EBV and HIV. In " Epstein-Barr Virus
and Human Disease ". 1988. pp. 489-494. Ed. D.V. Ablashi, et al. Published
by The Humana Press, Inc., Clifton, NJ. USA
Ablashi, D.H. Zompetta, C., Lease, C., Josephs, S.F., Balachandran, N.,
Komaroff, A.L., Krueger, G.R.F., Henry, B., Luka, J. and Salahuddin,
S.Z.: Human Herpesvirus-6 (HHV-6) and chronic fattigue syndrom (CFS). In "
Procedings of the Chronic Fattigue Syndrome Workshop". Published by:
Central Public Health Laboratory, Toronto, Canada. 1989.
Hartman, D.P., Luka, J., Deeb, Z.E., Pearson, G.R., Baldorlyc, K.P.:
The detection of EBV-induced early antigens in malignant head and neck tumors.
In: Proceedings of the Second International Head and Neck Oncology Research.
pp. 91-94. 1988.
Wu Ching Uen, Luka, J., Pearson,G.R.: Development of an enzyme linked
immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr
virus. Int. J. Cancer, 47. 479-482. 1988.
Luka, J.: Activation of Epstein-Barr virus in latently infected cell
lines. J. Virol. Methods, 21. 223-227. 1988.
Luka, J., Deeb, E.Z., Hartman, D.P., Jenson, B., Pearson, G.R.: Detection
of Epstein-Barr virus replication-associated antigens in nasopharyngeal carcinoma
biopsies. J. of the Natl Cancer Institute, 80. No. 14. 1164-1167. 1988.
Pearson, G.R., Luka, J., Petti, L., Sample, J., Birkenbach, M., Braun,
D., Kieff, E.: Identification of an Epstein-Barr virus early gene encoding
for a second component of the restricted early antigen complex. Virology,
160. 151-161. 1987.
Emini, E.A., Luka, J., Armstrong, M.E., Pearson, G.R.: Identification
of an Epstein-Barr virus glycoprotein which is antigenically homologous to
the Varicella-Zoster virus glycoprotein II and the Herpes Simplex virus glycoprotein
B. Virology, 157. 552-555. 1987.
Goldschmidts, W., Luka, J., Pearson, G.R.: A restricted component
of the Epstein-Barr virus early antigen complex is structurally related to
ribonucleotide reductase. Virology, 157. 220-226. 1987.
Luka, J., Anderson, C., Pearson, G.R.: Characterization of the suppressor
effect of B 95-8 virus on EA-inducing capability of P3HR-1 virus. In: Epstein-Barr
Virus and Human Disease. Levine, P.H., Ablashi, D.H., Nonoyama, M., Pearson,
G.R., Glaser, R. (Ed.s) Humana Press, N.J. USA pp. 305-308. 1987.
Takaoka, Y., Luka, J., Pearson, G.R.: Characterization of a major
EA-D component of the EBV induced complex. In: Epstein-Barr Virus and Human
Disease. Levine, P.H., Ablashi, D.H., Nonoyama, M., Pearson, G.R., Glaser,
R. (Ed.s) Humana Press, N.J. USA pp. 251-252. 1987.
Fox, R., Sportsman, R., Rhodes, G., Luka, J., Pearson, G.R., Vaughan,
J.: Rheumatoid arthritis synovial membrane contains a 62Kd protein that shares
antigenic epitope with the Epstein-Barr virus encoded EBNA-1 antigen. J. Clin.
Investigation, 77. 1539-1547. 1986.
Emini, E.A., Luka, J., Armstrong, M.E., Banker, F.S., Pearson, G.R.,
Provost, P.J.: Establishment and characterization of Epstein-Barr virus infection
in common marmosets. J. Med. Virology, 18. 369-379. 1986.
Pearson, G.R., Luka, J., Docherty, J.: Monoclonal antibodies in the
diagnosis of EBV-induced diseases. In: Human Herpesvirus Infections. C. Lopez,
B. Roizman, (Ed.s) Raven Press, N.Y. pp. 211-219. 1986.
Luka, J., Miller, G., Jörnvall, H., Pearson, G.R.: Characterization
of the restricted component of the Epstein-Barr virus early antigens as a
cytoplasmic filamentous protein. J. Virology, 58. 748-756. 1986.
Pearson, G.R., Luka, J.: Characterization of Epstein-Barr virus determined
antigens. In: Epstein-Barr Virus, (Recent Advances) M.A. Epstein and B.G.
Achong. (Ed.s) pp. 48-73. W. Heinemann Medical Books, 1986.
Gergely, L., Luka, J., Klein, G.: Interaction between Epstein-Barr
virus determined nuclear antigen (EBNA) and the viral DNA. J. Gen. Virology,
65. 2043-2048. 1984.
Vroman, B., Luka, J., Rodriguez, M., Pearson, G.R.: Characterization
of a major protein with a molecular weight of 160 000 associated with the
viral capsid of EBV. J. Virology, 53. 107-113. 1985.
Kallin, B., Sternas, L., Saemundsen, A.K., Luka, J., Jörnvall,
H., Eriksson, B., Pel-zhen Tao, Klein, G.: Purification of Epstein-Barr virus
associated DNA-polymerase from P3HR-1 cells. J. Virology, 54. 561-568. 1985.
Luka, J., Kreofsky, T., Spelsberg, T.C., Pearson, G.R., Hennesy,
K., Kieff, E.: Characterization of two forms of the 72 000 MW EBNA and a cross-reacting
cellular protein. In: Epstein-Barr Virus and Associated Diseases. Levine,
P.H. (Ed.) Martinus Nijhoff publishing, Boston, 1985.
Kishishita, M., Ito, Y., Luka, J., Pearson, G.R.: Localization of
Epstein-Barr virus early antigen (EA) by electron microscopy. In: Epstein-Barr
Virus and Associated Diseases. Levine, P.H., (Ed.) Martinus Nijhoff publishing,
Boston, 1985.
Luka, J., Chase, R.C., Pearson, G.: A sensitive enzyme linked immunosorbent
assay (ELISA) against the major EBV associated antigens. I. Correlation between
ELISA and immunofluorescence titers using purified antigens. J. Immunol. Methods,
67. 145-156. 1984.
Kishishita, M., Luka, J., Vroman, B., Pearson, G.R.: Production of
monoclonal antibody to a late intracellular Epstein-Barr virus induced antigen.
Virology, 133. 363-375. 1984.
Luka, J., Kreofsky, T., Pearson, G.R., Hennesy, K., Kieff, E.: Identification
and characterization of a cellular protein that crossreacts with the Epstein-Barr
virus nuclear antigen. J. Virology, 52. 833-838. 1984.
Sternas, L., Kallin, B., Luka, J., Klein, G.: Immunochemical characterization
of EBV-associated antigens detected by immunodiffusion. Intervirology, 17.
208-214. 1982.
Szigeti, R., Luka, J., Sternas,L., Klein, G.: Leukocyte migration
inhibition (LMI) studies on the EBV specific 48K subcomponent of EBNA and
the associated 53K cellular protein. Int. J. Cancer. 29. 413-420. 1982.
Jörnvall, H., Luka, J., Klein, G., Appela, E.: A cellular protein
common to chemically induced and virally transformed states shows extensive
sequence similarities between species. Proc. Natl. Acad. Sci. USA 79. 287-291.
1982.
Luka, J., Jörnvall, H.: The DNA-binding protein p53 in Epstein-Barr
virus transformed cells. Advances in Viral Oncology, Klein, G. (Ed.), vol.
2, Raven Press, 1982.
Luka, J., Jörnvall, H., Klein, G.: The EBV determined nuclear
antigen: A previously identified 48K component and higher molecular weight
forms of antigen are structurally related. Intervirology, 4. 213-222. 1983.
Szigeti, R., Klein, G., Luka, J., Volsky, D.J.: Epstein-Barr virus
antigének által kiváltot leukocytamigration gátlás;
Egészséges donorok válaszkészsége. Orvosi
Hetilap (In Hungarian, Budapest, Hungary) 122. 38. 1981.
Sternas, L., Luka, J., Kallin, B., Vestergaard, B.F., Klein, G.:
Detection and characterization of Epstein-Barr virus antigens by micro-ELISA
assay and chromatofocusing. J. Virol. Methods, 4. 229-240. 1982.
Sternas, L., Luka, J., Kallin, B., Rosen, A., Henle, W., Henle, G.,
Klein, G.: Enzyme-linked immunosorbent assay for the detection of Epstein-Barr
virus induced antigens and antibodies. J. Immunol. Methods. 63. 171-186. 1983.
Luka, J., Sternas, L., Jörnvall, H., Klein, G., Lerner, G.:
Antibodies of predetermined specifity for the NH2 terminus of a cellular protein
p53 react with the native molecule. Proc. Natl. Acad. Sci. USA 80. 1199-1203.
1983.
Jörnvall, H., Kalkhinen, N., Luka, J., Kaiser, R., Carlquist,
M., von Bahr-Lindström, H.: Protein studies as important tools in amplifying
different characterizations of biologically active macromolecules. In: Modern
Methods in Protein Chemistry, Tschesce, T. (Ed.) de Gryter, Berlin, New York,
1983.
Szigeti, R., Luka, J., Klein, G.: Leukocyte migration inhibition
studies with Epstein-Barr virus determined nuclear antigen (EBNA) in relation
to the EBV carrier status of the donor. Cellular Immunology. 58. 269-276.
1981.
Szigeti, R., Volsky, D.J., Luka, J., Klein, G.: Membranes of EBV-carrying
non-producer cells inhibit leukocyte migration of EBV-seropositive but not
seronegative donors. J. Immunology, 126. 1676-1686. 1981.
Roubal, J., Kallin, B., Luka, J., Klein, G.: Early DNA-binding polypeptides
of Epstein-Barr virus. Virology, 113. 285-292. 1981.
Klein, G., Luka, J., Zeuthen, J.: Transformation induced by Epstein-Barr
virus and the role of the nuclear antigen. Cold Spring Harbor Symp. on Quant.
Biol. 44. 253-261. 1980.
Roubal, J., Luka, J., Klein, G.: Effect of retionic acid (RA) on
the Epstein-Barr virus inducing effect of sodium butyrate. Cancer Letter,
8. 209-212. 1980.
Luka, J., Jörnvall, H., Klein, G.: Purification and biochemical
characterization of the EBV-determined nuclear antigen (EBNA) and an associated
protein with 53K subunit. J. Virology, 35. 592-602. 1980.
Lindahl, T., Luka, J., Ohno, S., Siegert, W., Klein, G.: Properties
of the Epstein-Barr virus determined nuclear antigen (EBNA). INSERM, 69. 161-164.
1978.
Luka, J., Kallin, B., Klein, G.: Induction of the Epstein-Barr virus
(EBV) cycle in latently infected cells by n-butyrate. Virology, 94. 228-231.
1979.
Shapiro, I., Luka, J., Andersson-Anvret, M., Klein, G.: Relationship
between Epstein-Barr virus genome number, amount of nuclear antigen and early
antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
Intervirology, 12. 19-25. 1979.
Ohno, S., Luka, J., Klein, G.: Evidence for antigenic distinctness
of the Epstein-Barr virus determined nuclear antigen and the Herpesvirus Papio
determined nuclear antigen. Cancer Letter, 6. 325-329. 1979.
Ohno, S., Luka, J., Klein, G., Daniel, M.D.: Detection of a nuclear
antigen in Herpesvirus Atales-carrying marmoset lines by the acid fixed nuclear
binding technique. Proc. Natl. Acad. Sci. USA 76. 2042-2046. 1979.
Kallin, B., Luka, J., Klein, G.: Immunochemical characterization
of Epstein-Barr virus (EBV) associated early and late antigens in n-butyrate
treated P3HR-1 cells. J. Virology, 32. 710-716. 1979.
Luka, J., Klein, G., Henle, W., Henle, G.: Detection of the EBV-determined
nuclear antigen (EBNA) in Burkitt's lymphoma and nasopharyngeal carcinoma
biopsies by the acid fixed nuclear binding technique. Cancer letter, 4. 199-205.
1978.
Luka, J., Lindahl, T., Klein, G.: Purification of the Epstein-Barr
virus determined nuclear antigen from Epstein-Barr virus transformed human
lymphoid cell lines. J. Virology, 27. 604-611. 1978.
Ohno, S., Luka, J., Lindahl, T., Klein, G.: Identification of a purified
complement-fixing antigen as Epstein-Barr virus determined nuclear antigen
(EBNA) by its binding to metaphase chromosomes. Proc. Natl. Acad. Sci. USA
74. 1605-1609. 1977.
Luka, J., Siegert, W., Klein, G.: Solubilization of the Epstein-Barr
virus determined nuclear antigen and its characterization as a DNA-binding
protein. J. Virol. 22. 1-8. 1977
Ohno, S., Luka, J., Falk, L., Klein, G.: Detection of a nuclear EBNA-type
antigen in apparently EBNA-negative Herpesvirus Papio (HVP)-transformed lymphoid
lines by the acid fixed nuclear binding technique. Int. J. Cancer, 20. 941-946.
1977.
Ohno, S., Luka, J., Falk, L., Klein, G.: Serological reactivities
of human and baboon sera against EBNA and Herpesvirus Papio determined nuclear
antigen (HUPNA). Eur. J. Cancer, 14. 955-960. 1977.
Lidman, K., Biberfeld, G., Fagreus, A., Carlson, L., Luka, J., Lindberg,
U.: Anti-actin specifity of human smooth muscle antibodies in chronic active
hepatitis. Clin. Exp. Immunology, 24. 266-272. 1976.
